Platelet-rich plasma (PRP) is blood plasma containing an above baseline level of platelets and growth factors. PRP is an emerging new treatment utilized to enhance wound healing and has been in clinical use over the last several decades within many disciplines, such as orthopedic, oral-maxillofacial and cardiac surgery. Recently, PRP has come to the attention of esthetic surgeons, with burgeoning new applications ranging from hair restoration to soft tissue augmentation. The goal of this review is to describe the current body of literature on PRP as it pertains to the field of esthetics, and to review its current real-world applications. PRP's utility in cosmetic surgery is rapidly growing and offers a promising and exciting new therapeutic modality.
INTRODUCTION
This article explores the clinical uses of platelet-rich plasma (PRP) in cosmetic surgery. PRP has been in clinical use over the last several decades and has been reported within many disciplines such as orthopedic, oral-maxillofacial and cardiac surgery. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] It has largely been investigated for its proposed ability to improve both hard and soft tissue wound healing. More recently, there has been a growing body of literature reporting its value in skin rejuvenation and augmentation of soft tissues in the realm of esthetics. It has been studied both in vitro and in animal models as well as in patients in various clinical settings. PRP is defined simply as plasma containing abovebaseline concentrations of platelets. 17 PRP is isolated through the centrifugation of whole blood and the resultant density-based separation of its contents. Simply put, its actions are based on the infusion of elevated concentrations of the growth factors secreted by activated platelets, thereby theoretically enhancing the biological healing capacity and tissue generation in the wound bed. Enzyme-linked immunosorbent assay studies of PRP have quantified the presence of 7, 10 and 30-fold increases in such growth factors as transforming growth factor (TGF)-, epidermal growth factor (EGF), platelet-derived growth factor (PDGF) respectively. 18 The process of wound healing is orchestrated by the complex interaction of a variety of biochemical mediators.
Platelets play a prominent role in part through their secretion of numerous biologically active proteins. 19 
CLINICAL APPLICATION OF PRP

Current Applications of PRP
Noncosmetic Applications of PRP
PRP has been used to augment wound healing in various clinical situations. Bony and cartilaginous repair using PRP has been studied in such settings as periodontal disease, sinus augmentation, bisphosphonate-related osteonecrosis of the jaw, mandibular bone grafts and degenerative joint disease. 34 Studies of soft tissue repair have examined disorders, such as rotator cuff injury, lateral epicondylitis, burns and chronic wounds. [35] [36] [37] [38] [39] These studies describe varying effects from equivalence with placebo saline or anesthetic injections, to decreased postoperative pain and faster rates of healing.
Hemostatic Properties of Autologous Blood Products
In the realm of plastic surgery, the use of autologous blood products was first introduced over 20 years ago in the form of fibrin glue, which was used as a hemostatic agent to promote adherence of skin flaps. 40 Early studies evaluating the use of fibrin glue in facelift patients demonstrated statistically significant decreases in both major hematoma formation and ecchymosis as well as elimination of the need for drains. 41 However, more recent comparative studies have tempered these results, showing minimal differences in the incidence of these adverse events despite use of fibrin glue. 42, 43 Fibrin glue is distinguished from PRP by its creation from platelet-poor plasma and primary composition of fibrinogen. By contrast, platelet gels contain higher concentrations of platelets and growth factors. Powell et al reviewed the effects of unilateral application of platelet gel in deep plane rhytidectomy in a small cohort of eight patients and found a nonsignificant trend for improved ecchymosis. 44 These initial investigations into the wound healing properties of autologous blood products were the early foundation for further studies exploring the rejuvenative properties of PRP.
PRP for the Treatment of Rhytids
In addition to the hemostatic properties of platelet-rich substances, the role of PRP in facial skin rejuvenation and the treatment of rhytids are also under investigation. The efficacy of PRP in the treatment of skin wrinkles has been explored using an animal model by Cho et al. 45 In this study, mice were first photoaged using UV-B irradiation for 8 weeks, and then divided into treatment groups either via PRP, normal saline or no treatment. Histologic assessment was subsequently performed using skin biopsy specimens, with the PRP-treated group demonstrating increased fibroblast and collagen production as well as increased dermal thickness. 45 These effects has been corroborated by clinical studies in humans. Redaelli et al (2010) reported their results of 23 consecutive patients who received injections with PRP once a month for 3 months, demonstrating clinical improvement in skin tonicity as well as reduction of facial rhytids. 46 
Augmentation of the Wound Healing Response
Given that platelets play a key role in the body's natural wound healing response, the role of PRP application in conjunction with other skin rejuvenation procedures has been investigated to elucidate its efficacy in potentially reducing surgical recovery time. With fractionated laser resurfacing, the vaporized holes in the skin are produced which act as avenues for drug delivery, facilitating easy topical administration of the PRP. Na et al examined the benefits of PRP in the wound healing process following fractional carbon dioxide laser resurfacing in 25 patients.
They noted a significant decrease in recovery time in the treatment of inner arm soft tissue with PRP compared to controls treated with normal saline, demonstrated by less transepidermal water loss, erythema and inflammatory pigmentation. 47 Similarly, Lee et al combined PRP with fractional carbon dioxide laser resurfacing for acne scars.
The authors compared the experimental PRP-treated facial half to the normal saline-treated control half in 14 patients and noted a significant decrease in erythema, edema and overall improved appearance on the PRP-treated side. 48 Recently, the senior author (GSK) has also explored the role of PRP in augmenting the skin healing response following CO 2 laser resurfacing procedures. CO 2 laser resurfacing of the face was performed with and without the topical application of PRP, with preliminary results demonstrating faster healing rates, decreased skin erythema (Fig. 1) . 49 Further investigation is currently ongoing.
Applications of Platelet-rich Fibrin Matrix
Platelet-rich fibrin matrix (PRFM) is a similar product to PRP that contains a smaller concentration of platelets. 50 Like PRP, it has been similarly utilized to augment healing while attempting to more closely mimic the natural wound response. 51 A calcium chloride solution is introduced to autologous blood, causing fibrin polymerization and development of a 3-dimensional matrix upon which platelets and growth factors are embedded. This scaffolding helps to localize growth factors to the targeted area. 51 Sclafani described its use in the treatment of facial acne scarring, reporting enhancement in appearance using subcision to lyse the scar-tethering subdermal bands with a Nocor needle (Becton, Dickinson and Co., Franklin Lakes, NJ) followed by subdermal injection of up to 2 to 4 cc of PRFM per cheek. 
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Role of PRFM and PRP in Soft Tissue Augmentation
Another promising use for both PRFM and PRP is as a soft tissue augmenting agent. Various injectable materials, including matrices, such as collagen and hyaluronic acid, have been used for years for esthetic soft tissue augmentation. However, these agents have demonstrated variable degrees of resorption, requiring repeat injections in order to maintain volume. In theory, combining a soft tissue augmenting agent, such as hyaluronic acid with PRP may be synergistic in its effect, as the HA acts as a scaffold upon which the PRP induces collagen and adipocyte generation. When injected in combination with conventional soft tissue fillers, PRP has been shown in animal models to both augment and maintain the tissue volumizing effect. 52 Runels has described the use of hyaluronic acid in combination with PRP in facial and breast injection augmentation. Promising esthetic results have been demonstrated using this technique, and outcomes studies are ongoing. 49 Even when used as a standalone agent without conventional fillers, PRP has demonstrated the ability to augment soft tissue. Sclafani has demonstrated good results with dermal augmentation in the nasolabial folds using PRFM. 53 In a series of 15 patients, the appearance of the nasolabial folds was improved in 1 to 2 weeks, with stable results at 12 weeks. Sclafani and McCormick performed histologic evaluations of full thickness skin biopsies taken from four subjects who had deep dermal and subdermal injections of PRFM. 54 They observed activated fibroblasts and new collagen deposition by day 7, and development of new blood vessels and intradermal adipocytes as well as stimulation of subdermal adipocytes by day 19. This study served to better elucidate the mechanism of volume enhancement observed after the injection of PRFM. Additionally, autologous fat grafting has been supplemented with PRP with the intent of enhancing graft take, with current studies illustrating mixed results. Salgarello et al observed no effect in a retrospective review of 42 women who underwent breast fat grafting using outcome parameters of ultrasound-graded liponecrosis and need for further grafting. 55 Cervelli et al reported the opposite findings, with improved subjective patient-reported outcomes as well as volume retention and revision grafting rates. 56 Sclafani 50 and Azzena 57 observed decreased ecchymosis and maintenance of volume in autologous fat transfer with PRFM.
Hair Restoration
Recently, the role of PRP for the treatment of hair loss has also proven promising. 
CLINICAL PREPARATION OF PRP
While many PRP preparation protocols exist, a common method involves drawing whole blood into a vial containing an anticoagulant. The blood is then centrifuged to separate the components based on variations in specific gravity: The bottom layer is comprised of red blood cells, the middle layer (often referred to as the buffy coat) white blood cells and platelets and the top layer plasma. The red blood cell portion is discarded, and the remaining plasma is centrifuged a second time to isolate the platelet-rich layer. Calcium chloride is then added to the resultant pellet of platelets and plasma, inducing platelet activation and release of alphagranule contents. [61] [62] [63] Secretion of granule contents begins and fibrin polymerization occurs within 10 minutes of the onset of the clotting process, thereby necessitating the application of the prepared plasma within this timeframe. 63 Another method of preparation involves drawing whole blood into a vial containing a separator gel. Upon centrifugation, the red and white blood cell layers are forced beneath the gel, on top of which settle the platelet layer and plasma. The platelets are then resuspended in the plasma by simply overturning the vial prior to use. The achievable concentration of platelets varies with the method of preparation employed, and has been reported from 2-to 8.5-fold over baseline (Table 1) .
Of note, surgical wounds induce platelet activation and decrease whole blood platelet count due to platelet concentration at the site of surgery. As these effects may interfere with the preparation of PRP, it has been suggested that blood be drawn prior to incision when surgery is concurrently performed. 9, 12, 17 Prior to activation, PRP can be stably maintained in an anticoagulated state for up to 8 hours for use throughout a lengthy surgical procedure. Currently, there are several commercially available systems which can be used for the preparation of autologous platelet-rich products. Selphyl (esthetic factors; Wayne, NJ, USA) and RegenKit (RegenLab; Lausanne, Switzerland) are two of the most commonly used systems, and are used to prepare PRFM and PRP respectively. Both of these systems have received FDA approval.
CONCLUSION
Many factors may influence the outcome of PRP usage, including platelet concentration and condition, amount of plasma used, the extent of injury at the site of treatment, and patient medical conditions. Such areas of potential clinical variability should be taken into account when examining the reported literature. The ease with which PRP can be prepared and applied heightens its appeal in cosmetic surgery. If studies continue to demonstrate desirable results, its adoption into practice could be easily facilitated.
